# Virtual reality as an assessment tool in neurorehabilitation: a scoping review of current evidence and future directions

**Authors:** Mohammed M. Alrashidi, Ahmed S. Alanazi, Shahad Alkhannani, Amirah Alharbi, Shahad Almuayrifi, Ayman A. Alhammad, Saad A. Alhammad, Abdulrhman S. Mashabi

PMC · DOI: 10.1186/s13102-025-01439-1 · BMC Sports Science, Medicine and Rehabilitation · 2025-12-01

## TL;DR

This review explores how virtual reality can be used to assess neurological conditions, finding it shows promise but needs more standardized research.

## Contribution

The study maps current VR-based assessment tools in neurorehabilitation and identifies key research gaps.

## Key findings

- VR assessments showed convergent validity ranging from moderate to excellent, with optical tracking systems performing better.
- Usability varied across conditions and modalities, with some physical tasks rated higher than VR tasks.
- Key gaps include limited normative data, inconsistent hardware/software, and lack of long-term evaluations.

## Abstract

Virtual reality (VR) technologies are increasingly applied in neurorehabilitation, but most research has focused on their therapeutic applications rather than assessment potential.

The aim of this scoping review was to map the evidence on VR-based assessment tools in neurorehabilitation, including types of tools, targeted neurological conditions, technological specifications, and research gaps.

A scoping review was conducted and reported in accordance with PRISMA-ScR. The protocol was prospectively registered in PROSPERO (CRD420251113260). Searches of PubMed, Scopus, Web of Science, The Cochrane Central Register of Controlled Trials (CENTRAL), IEEE Xplore, and grey literature were performed from inception to July 2025. Eligible studies involved VR for assessment purposes in neurological populations and reported validity, reliability, usability, or assessment performance. Data were charted and synthesised thematically.

Sixteen studies met the inclusion criteria. Most adapted established assessments such as the Box and Block Test, Action Research Arm Test, or Virtual Peg Insertion Test into VR formats. Populations included stroke, multiple sclerosis, Parkinson’s disease, cerebral palsy, spinal cord injury, and movement disorders. VR systems ranged from custom-built motion-tracking platforms to commercial head-mounted displays with controllers or optical hand-tracking. Convergent validity ranged from moderate to excellent (r = 0.65–0.99), with optical tracking and mixed reality systems (r > 0.90) generally outperforming controller-based approaches (r ≈ 0.65). Usability was often rated highly but varied across conditions and modalities, with some studies reporting higher usability ratings for physical tasks compared to VR. Key gaps included limited normative datasets, heterogeneous hardware/software, and minimal longitudinal evaluations.

VR-based assessments in neurorehabilitation remain a developing field. Preliminary evidence suggests good validity, usability, and feasibility, with potential to provide richer performance data that augment conventional assessment. However, large-scale, standardised, and condition-specific studies are required before widespread clinical implementation.

The online version contains supplementary material available at 10.1186/s13102-025-01439-1.

## Linked entities

- **Diseases:** stroke (MONDO:0005098), multiple sclerosis (MONDO:0005301), Parkinson’s disease (MONDO:0005180), cerebral palsy (MONDO:0006497), spinal cord injury (MONDO:0043797), movement disorders (MONDO:0005395)

## Full-text entities

- **Diseases:** concussion (MESH:D001924), stroke (MESH:D020521), traumatic brain injury (MESH:D000070642), PCC (OMIM:115700), CP (MESH:D002547), dystonia (MESH:D004421), Movement disorders (MESH:D009069), neglect (MESH:D058069), NHPT (MESH:D013736), HMDs (MESH:D006258), motor and perceptual deficits (MESH:D010468), Spinal cord injuries (MESH:D013119), Mounted (MESH:C537181), upper limb (MESH:D038062), intention tremor (MESH:D014202), MS (MESH:D009103), chorea (MESH:D002819), PD (MESH:D010300)
- **Chemicals:** BBT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12794368/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12794368/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12794368/full.md

---
Source: https://tomesphere.com/paper/PMC12794368